Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528233 | Clinical Therapeutics | 2018 | 10 Pages |
Abstract
Pretreatment with flibanserin 100 mg once daily for 2 weeks did not produce a clinically relevant change in oral contraceptive drug exposure following single-dose administration of ethinylestradiol/levonorgestrel. This finding is relevant to women with hypoactive sexual desire disorder who might prefer oral contraceptives to other forms of birth control. EudraCT No: 2006-006960-46.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Crista MD, MSc, Louise RPh, James MD, PhD, MBA, Robert MD, David J. MD,